(0.31%) 5 116.00 points
(0.30%) 38 353 points
(0.37%) 15 987 points
(-0.95%) $83.05
(5.36%) $2.03
(0.33%) $2 354.90
(0.56%) $27.69
(4.23%) $961.10
(-0.27%) $0.932
(-0.47%) $10.97
(-0.59%) $0.796
(1.63%) $93.37
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 10.30%
@ $66.00
発行日: 29 4月 2024 @ 22:33
リターン: 3.64%
前回のシグナル: 4月 26 - 23:47
前回のシグナル:
リターン: 1.20 %
Live Chart Being Loaded With Signals
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide...
Stats | |
---|---|
本日の出来高 | 481 055 |
平均出来高 | 852 225 |
時価総額 | 4.69B |
EPS | $0 ( 2024-02-22 ) |
次の収益日 | ( $1.550 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 14.71 |
ATR14 | $2.47 (3.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Niedzwiecki Daniel | Sell | 177 | Common Stock |
2024-04-17 | Blanchfield Paul | Sell | 455 | Common Stock |
2024-04-15 | Sabens Andrea | Sell | 341 | Common Stock |
2024-03-25 | Morgan Amanda Michelle | Sell | 0 | Common Stock |
2024-03-25 | Morgan Amanda Michelle | Sell | 10 310 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
16.09 |
Last 100 transactions |
Buy: 597 665 | Sell: 442 511 |
ボリューム 相関
Lantheus Holdings Inc 相関
10 最も負の相関 | |
---|---|
WTBA | -0.961 |
FGBI | -0.957 |
GNTY | -0.957 |
ALXO | -0.954 |
ALLK | -0.949 |
ACRX | -0.947 |
TNGX | -0.943 |
AROW | -0.941 |
MICS | -0.941 |
RDVT | -0.94 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Lantheus Holdings Inc 相関 - 通貨/商品
Lantheus Holdings Inc 財務諸表
Annual | 2023 |
収益: | $1.30B |
総利益: | $709.54M (54.73 %) |
EPS: | $4.79 |
FY | 2023 |
収益: | $1.30B |
総利益: | $709.54M (54.73 %) |
EPS: | $4.79 |
FY | 2022 |
収益: | $935.06M |
総利益: | $581.70M (62.21 %) |
EPS: | $0.410 |
FY | 2021 |
収益: | $425.21M |
総利益: | $187.70M (44.14 %) |
EPS: | $-1.054 |
Financial Reports:
No articles found.
Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。